Arcadia Biosciences's three largest insider shareholders as of April 22, 2026 are Stanley Jr Jacot (Chief Executive Officer, 5.00K shares), Thomas J. Schaefer (Chief Executive Officer, 2.82K shares), Mark Kawakami (Chief Financial Officer, 2.68K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Stanley Jr Jacot | Chief Executive Officer | 5,000 | 0 | 30 May, 2023 |
| Thomas J. Schaefer | Chief Executive Officer | 2,819 | 0 | 05 Feb, 2025 |
| Mark Kawakami | Chief Financial Officer | 2,681 | 0 | 05 Feb, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 May, 2025 | Mark Kawakami | Stock Option (Right to Buy) | A | 12,500 | $0.00 | 33,987 | D | A |
| 09 May, 2025 | Thomas J. Schaefer | Stock Option (Right to Buy) | A | 12,500 | $0.00 | 37,975 | D | A |
| 03 Feb, 2025 | Thomas J. Schaefer | Common Stock | A | 700 | $2.49 | 2,819 | D | P |
| 03 Feb, 2025 | Mark Kawakami | Common Stock | A | 700 | $2.49 | 2,681 | D | P |
| 01 Aug, 2024 | Thomas J. Schaefer | Common Stock | A | 700 | $2.06 | 2,119 | D | P |
| 19 Aug, 2024 | Amy Yoder | Stock Option (Right to Buy) | A | 10,909 | $0.00 | 13,442 | D | A |
| 19 Aug, 2024 | Gregory D Waller | Stock Option (Right to Buy) | A | 10,909 | $0.00 | 13,338 | D | A |
| 19 Aug, 2024 | Mark Kawakami | Stock Option (Right to Buy) | A | 20,000 | $0.00 | 21,487 | D | A |
| 19 Aug, 2024 | Lilian Shackelford Murray | Stock Option (Right to Buy) | A | 10,909 | $0.00 | 13,287 | D | A |
| 19 Aug, 2024 | Kevin Comcowich | Stock Option (Right to Buy) | A | 25,455 | $0.00 | 31,042 | D | A |
| 19 Aug, 2024 | Thomas J. Schaefer | Stock Option (Right to Buy) | A | 20,000 | $0.00 | 25,475 | D | A |
| 01 Aug, 2024 | Mark Kawakami | Common Stock | A | 700 | $2.06 | 1,981 | D | P |
| 01 Feb, 2024 | Thomas J. Schaefer | Common Stock | A | 700 | $2.06 | 1,419 | D | P |
| 04 Aug, 2023 | Thomas J. Schaefer | Common Stock | A | 649 | $3.67 | 719 | D | P |
| 06 Jun, 2023 | Amy Yoder | Stock Option (Right to Buy) | A | 937 | $0.00 | 2,533 | D | A |
| 06 Jun, 2023 | Gregory D Waller | Stock Option (Right to Buy) | A | 937 | $0.00 | 2,429 | D | A |
| 06 Jun, 2023 | Kevin Comcowich | Stock Option (Right to Buy) | A | 2,186 | $0.00 | 5,587 | D | A |
| 06 Jun, 2023 | Lilian Shackelford Murray | Stock Option (Right to Buy) | A | 937 | $0.00 | 2,378 | D | A |
| 30 May, 2023 | Stanley Jr Jacot | Common stock | A | 5,000 | $4.31 | 5,000 | D | P |
| 04 Apr, 2023 | Thomas J. Schaefer | Stock Option (Right to Buy) | A | 1,500 | $0.00 | 5,475 | D | A |